Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Twenty-five years ago

Early response to light therapy predicts longer-term antidepressant benefit in seasonal affective disorder

May 14, 2026

Leo Sher, M.D.

Our research work “Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder” was published 25 years ago in the 2001 issue of the Journal of Psychiatry and Neuroscience (1).

Our study examined whether patients with seasonal affective disorder (SAD) who improve very quickly after starting light therapy are more likely to experience sustained antidepressant benefits over time. We studied 12 patients with SAD who were treated with bright light therapy for two weeks at the National Institutes of Health Clinical Center. Depression severity was measured using the Structured Interview Guide for the Hamilton Depression Rating Scale–Seasonal Affective Disorder Version (SIGH-SAD) before treatment, after one hour of light exposure, and again after one and two weeks of therapy.

We found that some patients showed measurable improvement in atypical depressive symptoms after only one hour of light therapy. Importantly, this very early improvement correlated with better outcomes after two weeks of treatment. The findings suggest that an immediate response to light exposure may serve as a partial predictor of longer-term antidepressant benefit in SAD. However, the correlation was stronger for atypical symptoms—such as hypersomnia, fatigue, and increased appetite—than for typical depressive symptoms.

Because the sample size was small, we emphasized that the results should be interpreted cautiously and require replication in larger studies. Nevertheless, the study supported the idea that light therapy can produce rapid biological and mood effects in susceptible individuals. The paper also contributed to growing evidence that SAD has a strong relationship to circadian rhythms and environmental light exposure. Clinically, the study suggested that early response patterns could potentially help physicians identify which patients are most likely to benefit from continued light therapy. Overall, our article reinforced light therapy as an effective treatment for SAD while highlighting the possibility of using rapid symptom improvement as an early prognostic marker.

Reference

  1. Sher L, Matthews JR, Turner EH, Postolache TT, Katz KS, Rosenthal NE. Early response to light therapy partially predicts long-term antidepressant effects in patients with seasonal affective disorder. J Psychiatry Neurosci. 2001 Sep;26(4):336-8.

Related Posts

Twenty-five years ago /

Free thyroxine and thyroid-stimulating hormone levels in individuals with seasonal affective disorder

‹ FDA launches real-time clinical trial initiative › Blood alcohol concentration and suicide mortality in Finland

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Suicide risk in stock market investors and traders: Clinical and medico-legal perspectives
  • Artificial intelligence in clinical and legal practice: Epistemic, ethical, relational, and legal challenges
  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.